The initial plans for the site call for the development of a medical office building that will be home to primary and specialty care professionals. Additionally, a full array of imaging technologies are slated for the location.
News at USA Health
Stay up to date on the latest news from our providers, facilities and researchers at USA Health.
A recent discovery at the University of South Alabama College of Medicine shows there is a contributor in the body that helps fight viral infections.
Breakthrough technology is providing researchers at USA Health Mitchell Cancer Institute a more precise understanding of how cancer cells grow.
As the opioid crisis continues to impact communities across the world, a physician-scientist at USA Health has been named the principal investigator of an international phase II clinical trial to evaluate the safety of a drug for babies born with neonatal opioid withdrawal syndrome.
The Vigil vaccine is a genetically engineered vaccine made from cancer cells acquired from patients during surgery.
Research completed at the USA Health Mitchell Cancer Institute suggests that aggressive uterine cancer may respond better to immunotherapy than slower growing types.
Barnita Haldar, M.D., a fifth-year Ph.D. student in the University of South Alabama Basic Medical Sciences Graduate Program, recently published an article in the Journal of the Federation of American Societies for Experimental Biology.
University of South Alabama researchers recently received funding from local Lions Clubs that will be used to buy equipment for conducting high-quality vision research and training the next generation of vision scientists.
The article titled “Extracellular NAD+ enhances PARP-dependent DNA repair capacity independently of CD73 activity” outlines the importance of NAD+, also known as an “energy molecule.” NAD+ is essential for survival of every cell in the body, and plays an important role in cancer research and treatment efficacy.
Steve Lim, Ph.D., associate professor of biochemistry and molecular biology at the University of South Alabama College of Medicine, was awarded a one-year $50,000 grant to investigate the pathological contribution of vascular smooth muscle cells (VSMC) in atherosclerosis.
The goal of the study is to help determine how to better care for women who take part in the Bridge Program.
Jon Simmons, M.D., associate professor of surgery and pharmacology at the University of South Alabama College of Medicine, was one of five faculty members recently awarded the 2019 USA College of Medicine Faculty Intramural Grants Research Award.